1. 47Ca kinetic studies were performed in eight normal young adult males. Plasma, urinary and faecal stable and radioactive calcium and wholebody radioactivity were measured for up to 40 days after intravenous administration of the tracer.
Introduction
Compartmental models have been used for the interpretation of calcium tracer kinetics since the Correspondence: Dr B. L. Wajchenberg, Diabetes and Adrenal Unit, Hospital das Clinicas, S b Paulo, Brazil, South America. early studies of Bauer, Carlsson & Lindquist (1955 . Two- (Heaney, 1962 (Gonick & Brown, 1970) and four-compartmental models (Aubert & Milhaud, 1960; Neer, Berman, Fisher & Rosenberg, 1967; Phang, Berman, Finerman, Neer, Rosenberg & Hahn, 1969; Massin, Vallke & Savoie, 1974) have been used.
The present study was initially designed to provide accurate data using a four-compartment model to describe calcium kinetics in a homogeneous human group. The finding of a difference in 47Ca specific radioactivities in plasma and urine in five of the subjects led to a revised model which included a non-exchangeable plasma calcium compartment as previously suggested by Giese & Comar (1964) . This revised model has important implications for the conduct of future 47Ca kinetic studies.
Materials and methods
Eight normal young male volunteer subjects, age 20-30 years (mean 23-9, SD 3.9 years), height 162-174 cm and weight 49-76 kg (mean 62.1, SD 8.0), were studied. Each subject was equilibrated for 6 weeks and subsequently maintained on a diet of constant mineral composition providing 17.9-21.9 mmol of calcium, 32-3-39-8 mmol of phosphorus, 120 mmol of sodium and 100 mmol of potassium per day until the end of the study. The mineral composition of each diet was checked weekly by chemical analysis of a sample of a homogenized 1-day duplicate diet. The subjects engaged in a constant daily level of physical activity in the Physiotherapy Section.
After the diet equilibration period, 1 pCi of 47CaC1, (The Radiochemical Centre, Amersham, Bucks, U.K.; code CSS.lP, specific radioactivity 333-385 ,uCi/mg of calcium)/kg body weight was given intravenously on the morning of the first day of the study. Each of the subjects had previously given informed consent to the studies and the resulting radiation dose. The procedure was approved by the Ethical Committee of the Department of Medicine. The radiation dose was calculated by using the procedures recommended by the Medical Internal Radiation Dose Committee of the American Society of Nuclear Medicine and found to be less than 260 mrad for the whole body and less than 1 rad for bone, after taking into account the 47Sc contribution as well as that from the contaminant 45Ca, which was less than 2% at the time of shipment 2 days before administration.
Blood samples were collected from the opposite antecubital vein at 2, 4, 6, 8, 10, 15, 30, 60, 90, 120, 180, 240, 360 and 720 min after tracer injection and thereafter every 12 h for 12 days, and then daily at 08.00 hours for 12-16 days.
For the first 24 h after the radioactive calcium injection, urine was collected in glass bottles containing 10 ml of conc. HCI at 0.5, 1, 1.5, 2,3,4, 5, 6, 12 and 24 h. For the subsequent 29 days, 24 h pooled urine samples were collected. Faeces were collected in porcelain containers in 48 h batches for 30 days.
Stable calcium was measured in plasma, urine and stools by the method of Kramer & Tisdall modified by Clark & Collip (1923) with spectrophotometric reading (de Loureiro & Janz, 1944) . As an additional check on the urine calcium measurements 10 specimens from subject O.O.N. and 16 from various patients were also measured by atomic absorption flame spectrophotometry (Instrumentation Lab. Inc., Wilmington, Mass., U.S.A.; model 14-25 1 with double beam).
Radioactivity was assayed in plasma and in firstday urine samples in a well-type NaI(T1) scintillation detector with sufficient counting time to ensure a coefficient of variation of less than 3%. To eliminate the contribution from the 47Sc, a pulse height discriminator (Nuclear-Chicago 8725) was used with the threshold set at 0.4 MeV. All the remaining 24 h pooled urine and faecal collections, in homogenized volumes of 1500 and 500 ml respectively, had their radioactivity measured with the 20 cm diameter x 10 cm thick NaI(T1) crystal inside the background shield of the whole-body counter (see below). Care was taken to avoid errors in sample weighing, adsorption of calcium on glassware and differences in counting geometry between the different types of specimen.
Calcium specific radioactivities in spot urine samples collected immediately after blood withdrawal were also determined. Each 'spot' was assayed for radioactivity under the same geometrical conditions as the accompanying plasma samples.
Plasma samples from subjects O.O.N., I.S.C., J.R. and C.N., collected at 10, 30, 60, 90, 120, 180, 240, 360, 720 and 1440 min after tracer injection, were ultrafiltered at 10°C and constant pH (7.4) for 6 h by the method of Toribara, Terepka 8c Dewey (1957) , and the 47Ca specific radioactivities in plasma and its ultrafiltrate were compared.
To rule out the possibility of the existence of a slowly exchanging compartment in the proteinbound fraction of calcium, four pooled plasma samples were incubated in vitro with 47Ca and samples were periodically withdrawn (from 5 to 210 min) for ultrafiltration for 3 h at 37OC and at constant pH (7.4).
The whole-body retention of 47Ca was measured up to 30 or 40 days, in the whole-body counter of the Atomic Energy Institute of S5o Paulo, which consists of a single 20 cm diam x 10 cm thick NaI(T1) crystal located within a steel room and connected to a 400 channel analyser (Technical Measurements Corporation model 40 1). Here, energies below 0.400 MeV were also eliminated.
A phantom made of several plastic containers with a known amount of the tracer homogeneously distributed was used as reference standard for the whole-body retention. The first wholebody count was performed about 2 h after the tracer injection and the amount of tracer excreted at that time was noted.
Two types of geometry were used in the wholebody radioactivity counting. For the first 20 days the arc technique was employed. The subject was placed on a couch shaped as a circular arc with a 150 cm radius, the centre of the crystal being at the centre of curvature. From the third to the last day of the study, the chair geometry was also used, in which the centre of the detector was 55 cm equi-distant from the back of the chair and the seat. Counting efficiency of the arc geometry is not greatly affected by redistribution of the tracer within the body (Miller, 1962) , but it is about nine times lower than that of the chair geometry. The ratio of the count rates in both geometries was used as an index of the tracer redistribution. When this ratio became constant, after 10-20 days, only the high-sensitivity chair geometry was used, and the data were normalized to those from the arc geometry.
Data analysis
A model consisting of four reversible exchanging compartments (Neer et al., 1967; Phang et al., 1969) was used initially (Fig. la) . Definitions of the symbols and notations used in the mathematical models are shown at the end of this section. Compartment 1 represents the pool or calcium into which 47Ca was injected and which serves as a precursor to urinary and faecal radioactivity. Compartments 1-4 constitute the calcium labile pool. Stable calcium returning to the labile pool is assumed to enter compartment 1 , it being thought to represent mostly bone resorption. Since urinary and faecal radioactivity did not account for all the 47Ca lost from the body as reflected by the wholebody retention measurements, it was necessary to introduce an additional irreversible exit pathway, insensible loss, which is not directly measurable (Modesto Filho, 1973) .
Assuming that the mass of calcium in any compartment remains constant throughout the study, the calcium balance, 4 can be calculated as the difference between rates of calcium deposition into and removal from bone. Program SAAM Berman, 1965) was used to fit the model to the data on plasma activity, whole-body radioactivity and the radioactivity excreted in urine and faeces simultaneously, a Univac 1108 computer being used (at the National Bureau of Standards, Gaithersburg, Maryland, U.S.A.).
Although the model represented in Fig. l(a) could fit the data on radioactivity measurements, it did not take into account the difference between plasma and urine specific radioactivities found in five subjects. This was done by splitting compartment 1 into two moieties, one of them being exchangeable with the tracer injected and the other not (Fig. lb) . The return of stable calcium from deep bone was also split into two parts, one entering compartment 1 and the other compartment 6. The transient solution for this model, i.e. the parameters L, (see below), are the same as in the previous model, but the masses and consequently the flow rates are different.
There is a lack of information on the size of the non-exchangeable calcium plasma compartment. Nevertheless, an estimate of the magnitude can be made based on the suggestion by Veall & Parsons (1964) that the non-exchangeable calcium pool might include sulphate, some forms of phosphate and perhaps oxalate. From the expected values of these complexes (Walser, 1961) we have assumed the mass of compartment 6 to be 5% of that of compartment 1.
Definitions and notations specific to calcium metabolism L,, Fractional rate of calcium transfer into compartment i from compartment j, in units of days-'; L,, fractional rate constant for urinary calcium excretion; L,, fractional rate constant for endogenous faecal calcium excretion; L,, fractional rate constant for insensible losses; La, fractional rate constant for dietary calcium absorption; Lo+, fractional rate constant for calcium deposition in very slowly exchanging bone.
MI, Amount of calcium in compartment i of the labile calcium pool (mmol).
R, = L, x Mj: amount of calcium transferred into compartment i from compartment j (mmoyday).
ui, Calcium ingested in the diet (mmol/day); vu, calcium excreted in urine (mmoyday); up, total calcium excreted in faeces (mmoyday); of, endogenous calcium excreted in faeces (mmol/day); v,, calcium excreted in ways not directly measurable (insensible losses); u, = v, + (vf -v,): calcium absorbed from the gut (mmol/day); a= u,/v,: fractional calcium absorption; uo+, calcium deposited in very slowly exchanging bone (mmol/day); uo-, calcium returned to the labile pool from the very slowly exchanging bone (mmol/day).
A measured = v i -u, -uF -0,: calcium balance (mmol/day).
Results

Chemical calcium in urine
The percentage recovery of increasing amounts of calcium added to a urine sample with a known calcium content varied between 91 and 105% ( r = 0-989, P < 0.01, n = 10). The specificity was checked by serial dilutions of a urine specimen (four replicates at six different dilutions). The relationship between dilution factor and calcium content gave r = 0.991 ( P < 0.01). Measurement of sets of 20 samples from the same pooled urine gave coefficients of variation within assays and between assays of 4.2% and 6.1% respectively.
The ratio of the calcium content determined by the chemical method to that obtained by atomic absorption flame spectrophotometry in 26 urine specimens containing between 1 -68 and 5.58 mmol/l gave a mean value of 1.012 i-SEM 0.023.
Whole-body radioactivity measurements
The precision of the whole-body radioactivity measurements based on 10 replicates at different radioactivity concentrations was indicated by a coefficient of variation which only approached 5% at the end of the experimental period.
Metabolic data
Plasma calcium concentrations remained constant throughout the study at values between 2.37 and 2-57 mmol/l. The metabolic balance data are summarized in Table 1 . The detailed raw data for each subject, including the whole body 47Ca retention measurements, are deposited as Clinical Science Table no. 78/13 with the Librarian, the Royal Society of Medicine, 1 Wimpole Street, London W1M SAE, from whom copies can be obtained on request. 
J.S.S.
J.R.
C.N.
Plasma and urine specijic radioactivities
Plasma and both spot and 24 h urine specific radioactivity results were in good agreement throughout the study in three of the subjects (B.M.D., J.R. and C.N.) as shown in Fig. 2 (C.N. ).
In the remaining five subjects 47Ca specific radioactivities in the plasma were consistently greater than those in the urine samples at corresponding times as shown in Fig. 3 (O.O.N.) . The 24 h urine data in both Figures are plotted at the mid-period time.
The plasma ultrafiltrates from subjects O.O.N. and I.S.O. had slightly but consistently lower 47Ca specific radioactivities than the corresponding whole plasma samples (Fig. 4) . In subjects J.R. and C.N. the specific radioactivities of 47Ca in plasma and ultrafiltrate were the same.
The results of the 47Ca incubation of the four plasma samples indicated no change in the specific radioactivity of the ultrafiltrate with time, suggesting a rapid equilibration (less than 5 min) of 47Ca between the ultrafiltrate and the proteinbound calcium.
Calcium kinetics
The goodness of fit of all the available tracer data was indicated by the small degree of scatter about the calculated lines, except for the early part of the cumulative faecal radioactivity curve. No correction was made for the intestinal transit time.
Since the faecal radioactivity excretion curve reaches a plateau after the first 6-10 days, a lag in its timing does not greatly influence the final results.
The results of the compartmental analysis in the individual studies, the mean values and standard deviations are summarized in Tables 1, 2 and 3. In Table 2 are given the constant rate coefficients which are common to both models. Table 1 shows the steady-state parameters of compartmental analysis according to the series model indicated in Fig. l(a) , where there is a noticeable discrepancy between measured and calculated v, and A. Table 3 shows those values which could be influenced by assuming a non-exchangeable fraction of calcium in plasma equal to 5% of that in compartment 1. This assumption was not applicable to subject B.M.D. since it led to a negative L,, value. Only by assuming a greater fraction for non-exchangeable plasma calcium could a positive value of L,, be obtained. No significant discrepancies were observed between measured and calculated balances (A).
There is insufficient information to calculate the fractions of v, and vo-which enter compartment 6; therefore the values in Table 1 refer to total v, and V&.
Discussion
The results of the conventional stable calcium balance (-0.5 to +5.8 mmol/day) are in agree- ment with the published data (Neer et al., 1967) . The urinary calcium data showed a similar dispersion to that recorded by Neer et al. (1967) even though the ingested calcium was kept in a narrow range during the equilibration and balance periods. The calcium balance (A measured), taking into account the insensible losses, ranged between -2-5
and +3-5 mmoVday (Table 2) and showed a similar degree of variation. between subjgcts.
The four-compa%nent model (Fig. la) was chosen initially because it contained the minimum number of compartments necessary to fit the radioactivity data as judged by mathematical criteria (Berman & Schoenfeld, €956) . The average values for the calcium masses in compartments 1-4, as well as exchanges between Compartments, as reflected by the fractional rate constants L , ( Table  2) , were similar to those reported by Neer ef al. (1967) . However, the urinary calcium extraction rate u, calculated by using this model does not match the measured values. This discrepancy may be related to the differences in calcium specific radioactivities found between urine and plasma in several subjects.
Differences between specific radioactivities of plasma and urine after the administration of radioactive calcium have previously been reported in man (Dow & Stanbury, 1960; Spencer, Li, Samachson & Laszlo, 1960) , dogs (Wiester, Whitla & Goldsmith, 1963) and sheep (Giese & Comar, 1964) .
On the other hand, Briscoe & Ragan (1965) found higher specific radioactivities of urinary 45Ca than in the contemporaneous serum for the first 4 days after intravenous administration of the tracer to human subjects. These authors attributed the discrepancies between serum and plasma specific radioactivities to errors in the measurement of total urinary calcium by chemical methods. This explanation could hardly account for our own findings since we have compared both chemical and atomic absorption techniques and found no systematic difference which would account for the discrepancies observed in our own subjects.
On the basis of data published by Pearson (1965 ), Veal1 & Parsons (1964 suggested that a significant fraction of the urinary calcium is nonexchangeable by its failure to equilibrate with added 47Ca in 3-4 h at 37OC. They pointed out that a non-exchangeable pool in the plasma could be extremely small and yet account for as much as 50% of the calcium metabolized daily if it has a high turnover rate as a consequence of rapid renal excretion. Hodgkinson, Zarembski & Nordin (1967) found no evidence for the existence of calcium in complexes in normal urine and attributed the earlier findings to chemical analytical errors. Subsequently, Donath, Pearson, Raynaud & Royer (1968) found further evidence for the existence of non-exchangeable urinary calcium by using atomic absorption spectrophotometry and also confirmed the chemical results by neutron activation analysis. The small differences we have found in the specific radioactivity of the total plasma and ultrafiltrate are consistent with the hypothesis that there is a non-exchangeable calcium pool in plasma which does not bind to plasma proteins to the same extent as ionized calcium. This is unlikely to be due to chemical errors since this phenomenon was only observed in those subjects where there was a discrepancy between plasma and urine specific radioactivities.
The first model analysed ( Fig. la) has one degree of freedom more than the second model (Fig. lb) , which allows one to check its ability to represent the calcium kinetics by comparing the measured value of u, and consequently the stable calcium balance (A) with those calculated from the model. The second model (Fig. lb) uses the measured values of u, as input data, hence the calculated and observed stable calcium balance (A) always agree. This represents a constraint, but it does not invalidate the model which is consistent with all our available data and therefore gives a more general representation of calcium kinetics.
The availability of whole-body radioactivity counting data in addition to the urinary faecal radioactivity measurements allows the estimation of insensible losses of calcium. Cohn et al. (1964 Cohn et al. ( , 1965 ) also used whole-body retention data but they assigned different weighting factors for the several compartments used in the curve fitting, assuming that this would correct for the different efficiencies of the detector for each compartment. We have assumed that there were no significant differences in counting efficiencies, since we have used the arc technique during the first 10-20 days of the experiment and we have recorded radioactivity in the Compton regions as well as the photo-peak of the pray spectrum. Under these conditions, variations in counting efficiency due to redistribution of the tracer within the body can be considered to be negligible (Miller, 1962) . Hence the difference between whole-body radioactivity counting data and the retention data estimated by excreta measurements should reflect insensible losses. The mean of these losses as a percentage of the injected dose was 5.5 (SD 3.3) and 7.6 (SD 3.0) after 12 and 30 days respectively. These are in agreement with the findings of Joplin (1964) in 21 subjects of an average of 6% at 10-14 days after intravenous injection of 47Ca.
Direct measurements by Consolazio, Matoush, Nelson, Hackler & Preston (1962) gave a mean calcium excretion rate in sweat collected in plastic bags of 1.7 mmoyday at a temperature of 2loC, but insensible losses also include the calcium in desquamated cells. Careful measurements of total skin loss by Carr, Harrison & Nolan (1973) on two subjects showed that this was equal to about 3% of the combined urine and faecal excretion or about 0.35 mmoyday. In both our models the insensible losses were assumed to be from compartment 1 (Fig. 1) . It is possible that other compartments contribute to these losses, but the present data are insufficient to resolve this point.
